drugset / Trial / NCT01082081

Post-operative Dental Pain Study Comparing Analgesic Efficacy

NCT01082081 ↗

Phase 4 Completed 300 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

GlaxoSmithKline will be conducting this trial to compare analgesics efficacy of paracetamol 1000mg vs 500mg . The post-surgical dental pain model will be used to evaluate the analgesic efficacy of paracetamol. Each subject will be enrolled in the study for up to six weeks. The duration of the entire study will be approximately 16 weeks. Each subject will have to come to the clinic for three visits (Screening, Treatment and Follow up visits).

Timeline

Start
2009-10
Primary completion
2010-03
Completion
2010-03

Outcome

Met primary endpoint

registry analysis (superiority or other test); Paracetamol Caplet 1000 mg vs Placebo Caplet; p <0.0001; Adjusted Mean Difference 7.25 (95% CI 4.04 to 10.45); ANCOVA NCT01082081 ↗

registry analysis (superiority or other test); Paracetamol Caplet 1000 mg vs Paracetamol Caplet 500 mg; p = 0.0004; Adjusted Mean Difference 4.77 (95% CI 2.15 to 7.39); ANCOVA NCT01082081 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 500 mg —
Subject Acetaminophen Small molecule 1000 mg —

Indications

No indication recorded.